ArticleInternational ophthalmology2026
Generative artificial intelligence to augment ethical problem solving in ophthalmology: GPT-5.1 versus a human ethicist.
Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWhile many large language models (LLMs) have been extensively investigated for their clinical decision-making capabilities, few studies have characterized their abilities to reason through complex, open-ended ethics cases. This study compared GPT-5.1 and expert human ethicist responses to real-world ethical scenarios specific to ophthalmology.
methodsTen ethical scenarios from the American Academy of Ophthalmology's Ask the Ethicist website were randomly selected and presented to GPT-5.1 using ChatGPT. AI-generated responses were subsequently compared to those of the expert human ethicist using conventional readability metrics. A panel of 10 physicians independently rated all responses via 6-point and 5-point Likert scales for both outcomes of likelihood-of-use in their own careers and perceived patient impact, respectively.
resultsGPT-5.1 versus human ethicist responses differed significantly on Flesch Reading Ease (10.9 ± 9.6 vs. 25.4 ± 10.9, p = 0.002) and Gunning Fog Index (21.3 ± 1.9 vs. 19.5 ± 2.9, p = 0.037). For likelihood-of-use, median ratings were 4.1 [3.8-4.3] for human ethicist versus 5.0 [4.7-5.2] for GPT-5.1 responses (p = 0.013). Median ratings for perceived patient impact of human ethicist versus GPT-5.1 responses were 3.6 [3.3-3.7] versus 3.9 [3.8-4.4], p = 0.008. Inter-rater reliability was moderate for both outcomes and response sources (ICC [2, 10]: 0.56-0.69).
conclusionsCompared to human ethicist responses, GPT-5.1 responses demonstrated lower readability; however, GPT-5.1 responses received significantly higher ratings for both outcomes of likelihood-of-use and perceived patient impact, respectively. These results advocate for further explorations of GPT-5.1 and other LLMs as potentially useful tools for evaluating common bioethical challenges in ophthalmology.
Indexed as
Identifiers
42704533What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.